Moderna's COVID-19 Vaccine Supply Agreement with Israel
Israel has signed an agreement with Moderna Inc for the future purchase of its potential COVID-19 vaccine.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
The Gornitzky team advising Moderna was led by Partners Pinchas Rubin (Picture), Chaim Friedland, Jonathan Raff and Assaf Harel, together with associate Carolyn Zeimer and Giogdani, Dr. Jonathan Shiman and Josh Cohen.